 |
|
Nedocromil in the Outpatient Management of Asthma
Joseph M. Keenan, MD;
Leonard Bielory, MD;
Patrick C. Flamion, MD;
Linda B. Ford, MD;
Martin Murcek, MD;
Dennis R. Pyszczynski, MD;
Jay Selcow, MD;
Anthony Silvagni, DO, PharmD;
Martha Tarpay, MD;
Myron J. Zitt, MD
Arch Fam Med. 1995;4(10):835-841.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Zeiger RS, Heller S, Mellon MH, Wald J, Falkoff R, Schatz M. Facilitated referral to asthma specialists reduces relapses in asthma emergency room visits. J Allergy Clin Immunol. 1991;87:1160-1168.
PUBMED
2. National Asthma Education Program Expert Panel. Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Institutes of Health; 1991. NIH publication 91-3042. 3. National Heart, Lung, and Blood Institute. International Consensus Report on Diagnosis and Management of Asthma. Washington, DC: Dept of Health and Human Services; 1992. NIH publication 92-3091. 4. Dahl R, Pedersen B. Influence of nedocromil sodium on the dual asthmatic reaction after allergen challenge: a double-blind, placebo-controlled study. Eur J Respir Dis. 1986;69:263-265.
5. Manolitsas N, Trigg C, McAulay A, Norton A, Wang J, Davies RJ. Comparison of the effects of treatment with nedocromil sodium and salbutamol on bronchial mucosal inflammation in asthma. Eur Respir J Suppl. 1993;6:481S.
6. Kimata H, Fujimoto M, Mikawa H. Nedocromil sodium acts directly on human B cells to inhibit immunoglobulin production without affecting cell growth. Immunology. 1994;81:47-52.
PUBMED
7. Vignola AM, Chanez P, Lacoste P, et al. Nedocromil modulates the histamine induced expression of ICAM-1 and HLA DR molecules on bronchial epithelial cells. Am Rev Respir Dis. 1993;147:A45. Abstract.
8. Crimi N, Palermo F, Oliveri R, Palermo B, Polosa R, Mistretta A. Protection of nedocromil sodium on bronchoconstriction induced by inhaled neurokinin A (NKA) in asthmatic patients. Clin Exp Allergy. 1992;22:75-81.
PUBMED
9. Jackson DM, Pollard CE, Roberts SM. The effect of nedocromil sodium on isolated rabbit vagus nerve. Eur J Pharmacol. 1992;221:175-177.
PUBMED
10. Brogden RN, Sorkin EM. Nedocromil sodium: an updated review of its pharmacological properties and therapeutic efficacy in asthma. Drugs. 1993;45:693-715.
PUBMED
11. Cherniack RM, Wasserman SI, Ramsdell JW, et al. A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma. Chest. 1990;97:1299-1306.
PUBMED
12. Bianco S, Del Bono N, Grassi V, et al. Effectiveness of nedocromil sodium versus placebo as additions to routine asthma maintenance therapy: a multicenter, double-blind, group comparative trial. Respiration. 1989;56:204-211.
PUBMED
13. Fyans PG, Chatterjee PC, Chatterjee SS. A trial comparing nedocromil sodium (Tilade) and placebo in the management of bronchial asthma. Clin Allergy. 1986;16:505-511.
PUBMED
14. Lal S, Dorow PD, Venho KK, Chatterjee SS. Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease. Chest. 1993;101:438-447.
15. Wells A, Drennan C, Hoist P, Jones D, Rea H, Thornley P. Comparison of nedocromil sodium at two dosage frequencies with placebo in the management of chronic asthma. Respir Med. 1992;1986:311-316.
16. Bergmann K-CH, Bauer CP, Overlack A. A placebo-controlled, blind comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma. Curr Med Res Opin. 1989;11:533-542.
PUBMED
17. Harper GD, Neill P, Vathenen AS, Cookson JB, Ebdon P. A comparison of inhaled beclomethasone dipropionate and nedocromil sodium as additional therapy in asthma. Respir Med. 1990;84:463-469.
PUBMED
18. Littlewood JM, Johnson AW, Edwards PA, Littlewood AE. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet. 1988;1:115-116.
PUBMED
19. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone diproprionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics. 1993;92:64-77.
FREE FULL TEXT
20. Ali NJ, Capewell s, Ward MJ. Bone turnover during high dose inhaled corticosteroid treatment. Thorax. 1991;46:160-164.
FREE FULL TEXT
21. Packe GE, Douglas JG, McDonald AF, Robins SP, Reid DM. Bone density in asthmatics taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax. 1992;47:414-417.
FREE FULL TEXT
22. Lehmann EL. Nonparametrics: Statistical Methods Based on Ranks. San Francisco, Calfi: Holden-Day Inc; 1975. 23. Jones PW, de Amaral-Marques RJC, Bone MF, et al. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicenter trial. Eur Respir J. 1994;7:55-62.
ABSTRACT
24. Schwartz HJ, Kemp JP, Bianco S, et al. Highlights of the nedocromil sodium clinical study presentations. J Allergy Clin Immunol. 1993;92:204-209.
PUBMED
25. Carrasco E, Sepulveda R. The acceptability, safety and efficacy of nedocromil sodium in long-term clinical use in patients with perennial asthma. J Intern Med Res. 1988;16:394-401.
26. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992;326:862-866.
ABSTRACT
27. Bousquet J, Knani J, Dhivert H, Richard A, Ware JE Jr, Michel F-B. Quality of life in asthma: internal consistency and validity of the SF-36 Questionnaire. Am J Respir Crit Care Med. 1994;149:371-375.
ABSTRACT
28. Wahedna I, Wong CS, Wisniewski FZ, Pavord ID, Tattersfield AE. Asthma control during and after cessation of regular beta2-agonist treatment. Am Rev Respir Dis. 1993;148:707-712.
PUBMED
29. Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ. Longterm effects of a long-acting beta2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med. 1992;327:1198-1203.
ABSTRACT
30. Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet. 1993;342:833-837.
PUBMED
31. Sears MR. Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990;336:1391-1396.
PUBMED
32. Suissa S, Ernst P, Boivin J-F, et al. A cohort analysis of excess mortality in asthma and the use of inhaled β-agonists. Am J Respir Crit Care Med. 1994;149:604-610.
ABSTRACT
33. Physician's Desk Reference. Montvale, NJ: Medical Economics Data Production Co; 1994. 34. Creticos P, Burk J, Smith L, Comp R, Norman P, Findlay S. The use of twice daily nedocromil sodium in the treatment of asthma. J Allergy Clin Immunol. In press. 35. Condemi J, Pierantoni WN, Wald J, et al. Use of different spacers with nedocromil sodium (NED): comparative improvement in taste. Ann Allergy. 1995;74:89.
36. Callaghan B, Teo NC, Clancy L. Effects of the addition of nedocromil sodium to maintenance bronchodilator therapy in the management of chronic asthma. Chest 1992;101:787-792.
PUBMED
37. Wells A, Drennan C, Hoist P, Jones D, Rea H, Thornley P. Comparison of nedocromil sodium at two dosage frequencies with placebo in the management of chronic asthma. Respir Med. 1992;86:311-316.
PUBMED
|
